Advanced

A case of constrictive pericarditis during cabergoline treatment for hyperprolactinaemia.

Löndahl, Magnus LU ; Nilsson, Anders; Lindgren, Hans and Katzman, Per LU (2008) In European Journal of Endocrinology 158(4). p.583-585
Abstract
OBJECTIVE: Treatment with dopamine agonists has been associated with cardiopulmonary fibrotic reactions, predominantly in patients treated for Parkinson's disease. To our knowledge, these reactions have previously not been associated with low-dose cabergoline treatment for hyperprolactinaemia. METHOD: A case of constrictive pericarditis in a patient treated with cabergoline for hyperprolactinaemia is presented. The patient has been treated at a county hospital and a university hospital in southern Sweden. RESULTS: A 20-year-old woman with a 3-year history of amenorrhoea was referred to the department in 1992. From 2001 to 2005, she was given cabergoline, 0.5-1.5 mg/week. In 2005 a pericardectomy was performed due to fibrotic, constrictive... (More)
OBJECTIVE: Treatment with dopamine agonists has been associated with cardiopulmonary fibrotic reactions, predominantly in patients treated for Parkinson's disease. To our knowledge, these reactions have previously not been associated with low-dose cabergoline treatment for hyperprolactinaemia. METHOD: A case of constrictive pericarditis in a patient treated with cabergoline for hyperprolactinaemia is presented. The patient has been treated at a county hospital and a university hospital in southern Sweden. RESULTS: A 20-year-old woman with a 3-year history of amenorrhoea was referred to the department in 1992. From 2001 to 2005, she was given cabergoline, 0.5-1.5 mg/week. In 2005 a pericardectomy was performed due to fibrotic, constrictive pericarditis. CONCLUSIONS: Our present case suggests that constrictive pericarditis may develop even on low-dose cabergoline, which might indicate that this reaction, as opposed to valvular fibrosis, is not mediated by a 5-HT(2B) agonistic mechanism. (Less)
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
European Journal of Endocrinology
volume
158
issue
4
pages
583 - 585
publisher
Society of the European Journal of Endocrinology
external identifiers
  • pmid:18362307
  • wos:000254993300018
  • scopus:41749084421
ISSN
1479-683X
DOI
10.1530/EJE-07-0584
language
English
LU publication?
yes
id
d524b554-555f-41ce-be50-39626a31307a (old id 1052197)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/18362307?dopt=Abstract
date added to LUP
2008-04-02 11:59:10
date last changed
2017-08-06 04:44:07
@article{d524b554-555f-41ce-be50-39626a31307a,
  abstract     = {OBJECTIVE: Treatment with dopamine agonists has been associated with cardiopulmonary fibrotic reactions, predominantly in patients treated for Parkinson's disease. To our knowledge, these reactions have previously not been associated with low-dose cabergoline treatment for hyperprolactinaemia. METHOD: A case of constrictive pericarditis in a patient treated with cabergoline for hyperprolactinaemia is presented. The patient has been treated at a county hospital and a university hospital in southern Sweden. RESULTS: A 20-year-old woman with a 3-year history of amenorrhoea was referred to the department in 1992. From 2001 to 2005, she was given cabergoline, 0.5-1.5 mg/week. In 2005 a pericardectomy was performed due to fibrotic, constrictive pericarditis. CONCLUSIONS: Our present case suggests that constrictive pericarditis may develop even on low-dose cabergoline, which might indicate that this reaction, as opposed to valvular fibrosis, is not mediated by a 5-HT(2B) agonistic mechanism.},
  author       = {Löndahl, Magnus and Nilsson, Anders and Lindgren, Hans and Katzman, Per},
  issn         = {1479-683X},
  language     = {eng},
  number       = {4},
  pages        = {583--585},
  publisher    = {Society of the European Journal of Endocrinology},
  series       = {European Journal of Endocrinology},
  title        = {A case of constrictive pericarditis during cabergoline treatment for hyperprolactinaemia.},
  url          = {http://dx.doi.org/10.1530/EJE-07-0584},
  volume       = {158},
  year         = {2008},
}